Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Phospho-CD79A (Tyr210) (E8E9Z) Rabbit mAb (Alexa Fluor® 488 Conjugate)


Cell Signalling Technology logo
View Antibody details

Phospho-CD79A (Tyr210) (E8E9Z) Rabbit mAb (Alexa Fluor® 647 Conjugate)


Cell Signalling Technology logo
View Antibody details

Phospho-CD79A (Tyr210) (E8E9Z) Rabbit mAb (PE Conjugate)


Cell Signalling Technology logo
View Antibody details

Phospho-CDK5 (Tyr15) (E6C8N) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-Chk2 (Thr68) (E8Q1A) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-Chk2 (Thr68) (E8Q1A) Rabbit mAb (PE Conjugate)


Cell Signalling Technology logo
View Antibody details

Phospho-CrkL (Tyr207) (E9A1U) XP® Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-eIF4E (Ser209) (F4E5N) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-Ezh2 (Thr311) (F1K1B) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-Ezh2 (Thr345) (E7T7K) Rabbit mAb


Cell Signalling Technology logo
View Antibody details